Impact of obesity on low density lipoprotein plasmatic levels 6 weeks after an acute coronary syndrome
Despite high-intensity statin prescription, the target was achieved by 67.6% of obese subjects and 44.8% of subjects with a BMI of less than 30 kg/m<sup>2</sup>. This shows that post-SCA management needs to be reinforced for the general population.
Authors
- Cyril Breuker (ORCID: https://orcid.org/0000-0002-9023-2686)
- François Roubille (ORCID: https://orcid.org/0000-0002-5288-9687)
- Nicolas Chapet
- M. Brobst
- Ariane Sultan (ORCID: https://orcid.org/0000-0002-9540-8222)
- Fanchon Herman (ORCID: https://orcid.org/0009-0000-8358-5320)
- E. Bourgeois (ORCID: https://orcid.org/0009-0008-4047-7440)
- Nicolas Molinari (ORCID: https://orcid.org/0000-0002-1786-0088)
- Daylale Benchalkha
Institutions
- Endocrinology Research Center (RU)
- Centre Hospitalier Universitaire de Montpellier (FR)
- Health Information Management (BE)
Publication Details
- Journal
- Cardiovascular Endocrinology & Metabolism
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1097/xce.0000000000000320
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Pfizer
- Sanofi
- Alnylam Pharmaceuticals
- Servier